Valuation: Camurus AB

Market Cap 34.1B 3.53B 3.09B 2.85B 2.64B 5.02B 337B 5.09B 13.27B 165B 13.26B 12.97B 573B P/E 2026 *
37.8x
P/E 2027 * 20.5x
Enterprise Value 29.76B 3.08B 2.7B 2.49B 2.31B 4.38B 294B 4.44B 11.58B 144B 11.57B 11.32B 500B EV / Sales 2026 *
10.6x
EV / Sales 2027 * 6.95x
Free-Float
64.67%
Yield 2026 *
-
Yield 2027 * -
1 day+1.66%
1 week+4.51%
Current month+2.48%
1 month+7.41%
3 months+22.78%
6 months-8.60%
Current year-5.93%
1 week 556
Extreme 556
590.5
1 month 490
Extreme 490
590.5
Current year 430.8
Extreme 430.8
710
1 year 430.8
Extreme 430.8
754.5
3 years 271.4
Extreme 271.4
754.5
5 years 120
Extreme 120
754.5
10 years 58
Extreme 58
754.5
Manager TitleAgeSince
Chief Executive Officer 63 01/01/2003
Director of Finance/CFO 57 01/07/2025
Chief Tech/Sci/R&D Officer 58 01/01/2025
Director TitleAgeSince
Director/Board Member 63 01/01/2002
Chairman 77 01/01/2015
Director/Board Member 61 07/05/2020
Date Insider Type Main position Quantity % Market Cap.
02-27Sell

Chief Executive Officer

1,500 0.0025%
02-27Sell

Chief Executive Officer

9,950 0.0166%
02-27Sell

Chief Executive Officer

55,550 0.0928%
Change 5-day change 1-year change 3-year change Capi.($)
+1.13%+4.51%-14.15%+103.19% 3.54B
-0.80%-2.05%+55.88%+160.09% 1,082B
-1.42%+0.13%+66.70%+60.17% 633B
-2.00%+0.61%+36.36%+86.42% 461B
-2.79%+1.37%+31.00%+23.05% 338B
-2.46%-1.38%+37.99%+36.52% 299B
-2.20%-0.87%+28.16%+42.69% 291B
-1.77%+1.97%-27.22%-40.66% 222B
-1.86%+1.80%+25.29%+64.61% 202B
-1.44%+2.34%+15.66%+69.57% 163B
Average -1.58%+4.41%+25.57%+60.57% 369.59B
Weighted average by Cap. -1.69%+5.43%+40.89%+80.68%

Financials

2026 *2027 *
Net sales 2.81B 291M 255M 235M 218M 414M 27.75B 419M 1.09B 13.62B 1.09B 1.07B 47.23B 4.06B 421M 368M 339M 315M 598M 40.11B 606M 1.58B 19.69B 1.58B 1.54B 68.27B
Net income 897M 92.88M 81.35M 74.93M 69.55M 132M 8.86B 134M 349M 4.35B 349M 341M 15.08B 1.65B 171M 150M 138M 128M 244M 16.35B 247M 644M 8.02B 644M 629M 27.82B
Net Debt -4.34B -450M -394M -363M -337M -639M -42.89B -648M -1.69B -21.05B -1.69B -1.65B -72.99B -5.88B -609M -533M -491M -456M -866M -58.1B -878M -2.29B -28.52B -2.29B -2.24B -98.87B
Logo Camurus AB
Camurus AB is a Sweden-based research and development based pharmaceutical and biotechnology company with a focus on the development and marketing of specialty medicines, providing patients suffering from severe and chronic disease, such as opioid dependence, pain, cancer, and endocrine diseases. The Company has a diversified research portfolio, which includes products in clinical trials. The Company’s products are based on FluidCrystal formulation technology. FluidCrystal is Company's patent-protected technology platform. Camurus AB is the parent company of the Group, which comprises of legal entities, namely: Camurus Inc, Cubosome Inc, Development AB, Camurus GmbH, Camurus Ltd, Camurus Oy, Camurus AS, Camurus SAS, Camurus Pty Ltd, Camurus S.L, Camurus ApS, Camurus BV and Camurus Austria GmbH.
Employees
308
Date Price Change Volume
06/07/26 SEK 579.50 +1.13% 92,409
03/07/26 SEK 573.00 -2.05% 67,918
02/07/26 SEK 585.00 +1.39% 69,590
01/07/26 SEK 577.00 +2.03% 83,479
30/06/26 SEK 565.50 +1.98% 76,791
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
573.00SEK
Average target price
769.50SEK
Spread / Average Target
+34.29%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CAMX Stock